NFATC2 and metastatic malignant neoplasm: Nevertheless, enhanced expression of NFATc2 has been reported in patients with metastatic cancers, invasive cancers, and highly malignant cancers [34,43,44,45], suggesting that functional changes in NFATc2 may induce angiogenic dysregulation in cancer cells.